102 related articles for article (PubMed ID: 9506361)
1. Differential induction of cell death in human glioma cell lines by sodium nitroprusside.
Blackburn RV; Galoforo SS; Berns CM; Motwani NM; Corry PM; Lee YJ
Cancer; 1998 Mar; 82(6):1137-45. PubMed ID: 9506361
[TBL] [Abstract][Full Text] [Related]
2. The role of protein kinase Calpha in U-87 glioma invasion.
Cho KK; Mikkelsen T; Lee YJ; Jiang F; Chopp M; Rosenblum ML
Int J Dev Neurosci; 1999; 17(5-6):447-61. PubMed ID: 10571407
[TBL] [Abstract][Full Text] [Related]
3. Antisense-mediated inhibition of the bcl-2 gene induces apoptosis in human malignant glioma.
Julien T; Frankel B; Longo S; Kyle M; Gibson S; Shillitoe E; Ryken T
Surg Neurol; 2000 Apr; 53(4):360-8; discussion 368-9. PubMed ID: 10825522
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells.
Mandil R; Ashkenazi E; Blass M; Kronfeld I; Kazimirsky G; Rosenthal G; Umansky F; Lorenzo PS; Blumberg PM; Brodie C
Cancer Res; 2001 Jun; 61(11):4612-9. PubMed ID: 11389098
[TBL] [Abstract][Full Text] [Related]
5. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
[TBL] [Abstract][Full Text] [Related]
6. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
[TBL] [Abstract][Full Text] [Related]
7. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
Le XF; Marcelli M; McWatters A; Nan B; Mills GB; O'Brian CA; Bast RC
Oncogene; 2001 Dec; 20(57):8258-69. PubMed ID: 11781840
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C isoform alpha overexpression in C6 glioma cells and its role in cell proliferation.
Baltuch GH; Dooley NP; Rostworowski KM; Villemure JG; Yong VW
J Neurooncol; 1995; 24(3):241-50. PubMed ID: 7595754
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.
Baltuch GH; Couldwell WT; Villemure JG; Yong VW
Neurosurgery; 1993 Sep; 33(3):495-501; discussion 501. PubMed ID: 8413883
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C.
Couldwell WT; Antel JP; Yong VW
Neurosurgery; 1992 Oct; 31(4):717-24; discussion 724. PubMed ID: 1407458
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.
Chen TC; Su S; Fry D; Liebes L
Cancer; 2003 May; 97(9 Suppl):2363-73. PubMed ID: 12712458
[TBL] [Abstract][Full Text] [Related]
12. Identification of PKCalpha isoform-specific effects in cardiac myocytes using antisense phosphorothioate oligonucleotides.
Kerkelä R; Ilves M; Pikkarainen S; Tokola H; Ronkainen J; Vuolteenaho O; Leppäluoto J; Ruskoaho H
Mol Pharmacol; 2002 Dec; 62(6):1482-91. PubMed ID: 12435817
[TBL] [Abstract][Full Text] [Related]
13. Human glioma cell sensitivity to the sequence-specific alkylating agent methyl-lexitropsin.
Bobola MS; Varadarajan S; Smith NW; Goff RD; Kolstoe DD; Blank A; Gold B; Silber JR
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):612-20. PubMed ID: 17255284
[TBL] [Abstract][Full Text] [Related]
14. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
Han J; Chen Q
Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
[TBL] [Abstract][Full Text] [Related]
15. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
Wang XY; Repasky E; Liu HT
Exp Cell Res; 1999 Jul; 250(1):253-63. PubMed ID: 10388539
[TBL] [Abstract][Full Text] [Related]
16. Disparity in expression of protein kinase C alpha in human glioma versus glioma-derived primary cell lines: therapeutic implications.
Zellner A; Fetell MR; Bruce JN; De Vivo DC; O'Driscoll KR
Clin Cancer Res; 1998 Jul; 4(7):1797-802. PubMed ID: 9676858
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
Sypniewski D; Bednarek I; Gałka S; Loch T; Błaszczyk D; Sołtysik D
Acta Pol Pharm; 2013; 70(1):87-97. PubMed ID: 23610963
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
19. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
